Cubist Systematic Strategies, LLC Vaxart, Inc. Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.56 - $1.41 $34,488 - $86,836	-61,586 Reduced 22.19%	215,977 $280,000
Q4 2023 Feb 14, 2024	BUY	$0.57 - $0.85 $1,935 - $2,885	3,395 Added 1.24%	277,563 $158,000
Q3 2023 Nov 14, 2023	SELL	$0.69 - $0.85 $53,470 - $65,869	-77,493 Reduced 22.04%	274,168 $205,000
Q2 2023 Aug 14, 2023	BUY	$0.6 - $1.41 $204,665 - $480,963	341,109 Added 3232.65%	351,661 $256,000
Q1 2023 May 15, 2023	BUY	$0.71 - $1.25 $7,491 - $13,190	10,552 New	10,552 $8,000
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $228,230 - $491,404	109,201 Added 75.52%	253,801 $553,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $325,652 - $636,831	120,612 Added 502.8%	144,600 $506,000
Q1 2022 May 16, 2022	BUY	$4.29 - $6.64 $102,908 - $159,280	23,988 New	23,988 $121,000
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $110,114 - $151,908	-19,084 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $18,722 - $27,508	-2,807 Reduced 12.82%	19,084 $152,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $10.78 $3,587 - $7,643	-709 Reduced 3.14%	21,891 $164,000
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $45,503 - $188,226	-8,068 Reduced 26.31%	22,600 $137,000
Q4 2020 Feb 16, 2021	SELL	$3.5 - $7.98 $105,168 - $239,783	-30,048 Reduced 49.49%	30,668 $175,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $290,222 - $1.03 Million	60,716 New	60,716 $404,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.